ecteinascidin 743 has been researched along with Prostatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atmaca, H; Ilhan, S; Oğuz, F | 1 |
| Daignault, S; Hofbauer, LC; Jones, JD; Koh, AJ; McCauley, LK; Paige, D; Roca, H; Shiozawa, Y; Sinder, BP; Soki, FN; Thiele, S | 1 |
| Acikgoz, E; Duzagac, F; Guven, U; Kara, M; Oktem, G; Soner, BC; Uslu, R | 1 |
| Bellmunt, J; Cullell-Young, M; Goel, S; Hudes, GR; Kahatt, C; Kantoff, PW; Lardelli, P; Lee, RJ; Lewis, NL; Michaelson, MD; Nieto, A; Pardos, I; Smith, MR; Stein, CA | 1 |
1 trial(s) available for ecteinascidin 743 and Prostatic Neoplasms
| Article | Year |
|---|---|
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cohort Studies; Dioxoles; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Treatment Failure; Treatment Outcome | 2012 |
3 other study(ies) available for ecteinascidin 743 and Prostatic Neoplasms
| Article | Year |
|---|---|
Trabectedin (ET-743) in prostate cancer: Endoplasmic reticulum stress-induced apoptotic effect.
Topics: Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Male; Prostatic Neoplasms; Reactive Oxygen Species; Trabectedin | 2022 |
Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bone Marrow; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Models, Animal; Humans; Immunohistochemistry; Macrophage Activation; Macrophages; Male; Mice; Phagocytosis; Phenotype; Prostatic Neoplasms; Trabectedin; Xenograft Model Antitumor Assays | 2019 |
Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cadherins; Caspases; Cell Adhesion; Cell Division; Cell Proliferation; Colony-Forming Units Assay; Dioxoles; Fluorescent Antibody Technique; G2 Phase; Humans; Male; Neoplastic Stem Cells; Prostatic Neoplasms; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 2015 |